Ignite Creation Date:
2024-05-06 @ 8:16 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06312111
Status:
COMPLETED
Last Update Posted:
2024-03-15
First Post:
2024-03-08
Brief Title:
Physical Activity and Various Aspects of Quality of Life in Patients With Pulmonary Arterial Hypertension Ph-PAH
Sponsor:
Centre of Postgraduate Medical Education
Organization:
Centre of Postgraduate Medical Education
Study Overview
Official Title:
Assessment of Physical Activity and Various Aspects of Quality of Life in Patients With Pulmonary Arterial Hypertension
Status:
COMPLETED
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PhA-PAH
Brief Summary:
Evaluate whether education a simple doctors recommendation to increase physical activity in inactive patients and self-monitoring of physical activity using a pedometer were effective and beneficial for patients with pulmonary arterial hypertension PAH
Detailed Description:
Each patient was educated about the benefits of PhA in PAH on the initial visit Patients wore pedometers Omron HJ-321-E for 2 weeks After PhA assessment the patients were contacted by a physician Patients who walked 5000 steps per day were recommended to increase PhA and patients who walked 5000 steps per day were recommended to maintain PhA Patients wore pedometers for 3 months until their next visit The primary endpoint was the number of steps after 12 weeks of the study the secondary endpoint was the 6-minute walk test distance 6MWD quality of life SF-36 acceptance of the disease and anxiety and depression level HADS
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None